Cano Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Cash & Equivalents	27.33	163.17	33.81	29.19
Cash & Cash Equivalents	27.33	163.17	33.81	29.19
Cash Growth	-83.25%	382.65%	15.81%	-
Receivables	233.82	133.43	67.35	49.25
Inventory	0	0	0.92	0.65
Other Current Assets	79.6	20.63	8.94	3.79
Total Current Assets	340.75	317.24	111.02	82.88
Property, Plant & Equipment	309.22	217.43	38.13	19.15
Long-Term Investments	0	0	-0.13	4.5
Goodwill and Intangibles	1,274	1,595	460.68	217.7
Other Long-Term Assets	4.82	13.58	4.5	1.85
Total Long-Term Assets	1,588	1,826	503.17	243.2
Total Assets	1,929	2,144	614.19	326.08
Accounts Payable	105.73	80.83	31.37	12.72
Deferred Revenue	0	0	5.27	0
Current Debt	32.2	23.06	5.99	2.11
Other Current Liabilities	70.51	57.14	24.56	71.32
Total Current Liabilities	208.44	161.04	67.18	86.15
Long-Term Debt	1,168	1,040	459.2	134.03
Other Long-Term Liabilities	58.7	143.55	38.19	7.44
Total Long-Term Liabilities	1,226	1,184	497.39	141.47
Total Liabilities	1,435	1,345	564.57	227.62
Total Debt	1,200	1,063	465.19	136.13
Debt Growth	12.81%	128.61%	241.72%	-
Retained Earnings	-286.03	-78.76	-107.83	-25.04
Comprehensive Income	0	0	0	-0.13
Shareholders' Equity	252.63	318.73	49.63	98.07
Net Cash / Debt	-1,172.39	-900.28	-431.38	-106.94
Net Cash Per Share	-534.93	-189.25	-500.15	-
Working Capital	132.31	156.2	43.84	-3.27
Book Value Per Share	115.27	186.93	57.54	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).